Less common but more serious concerns include pancreatitis (rare but reportable), gallbladder issues, and potential thyroid C-cell tumor risk seen in rodent studies
The recommended dose is 5 mcg twice daily initially, which may be increased to 10 mcg twice daily after one month based on clinical response and tolerability
Our healthcare providers carefully evaluate each patients individual health profile and discuss potential benefits and risks of tirzepatide treatment
Wang B, Song R, He W, Yao Q, Li Q, Jia X, Zhang JA
Here are the most common GLP-1 drugs: Semaglutide (Ozempic, Rybelsus) Exenatide (Byetta, Bydureon) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Lixisenatide (Adlyxin) Albiglutide (withdrawn from the market) Exenatide Extended-Release (Bydureon) Efpeglenatide (Lyxumia, ZYOG1) Out of all, the most popular is Semaglutide
This ripple effect will be felt across industries ranging from food and beverage to pharmaceuticals to consumer goods